Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
May 10, 2013 sing george l Director Option Execute 5,000 15.01
May 18, 2010 sing george l Director Buy 5,000 28.44
May 27, 2015 sing george l Director Sell 5,000 515.00
May 10, 2013 sing george l Director Sell 5,000 270.00
Aug 22, 2012 sing george l Director Sell 5,000 139.00
Aug 23, 2012 sing george l Director Sell 5,000 142.00
Jul 26, 2012 sing george l Director Sell 5,000 135.00
May 30, 2012 sing george l Director Sell 5,000 134.00
May 31, 2012 sing george l Director Sell 5,000 134.74 - 135.15
Nov 13, 2012 sing george l Director Sell 5,000 148.00
Nov 16, 2012 sing george l Director Sell 5,000 152.00
Nov 29, 2012 sing george l Director Sell 5,000 185.00
Feb 14, 2011 terifay robert j Officer Automatic Sell 5,000 37.02
Feb 14, 2011 terifay robert j Officer Option Execute 5,000 21.34
Aug 5, 2015 tessier-lavigne marc Director Option Execute 5,000 57.11
Aug 5, 2015 tessier-lavigne marc Director Sell 5,000 584.07 - 595.44
Oct 1, 2008 mccorkle douglas s Officer Automatic Sell 5,034 21.22 - 22.16
Oct 1, 2008 mccorkle douglas s Officer Option Execute 5,034 8.50 - 13.00
Nov 10, 2015 van plew daniel p Officer Sell 5,123 551.45 - 557.14
Aug 18, 2014 aberman michael s Officer Automatic Sell 5,139 351.06
Showing 341-360 of 1021 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)